Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1

Pharmacology, Toxicology and Pharmaceutical Science

• Plasminogen Activator Inhibitor 1 100%
• Insulin 50%
• Messenger RNA 37%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 25%
• Cardiovascular Risk 18%
• Protein 12%
• Western Blot 12%
• 2 (2 Amino 3 Methoxyphenyl)chromone 6%
• Mouse 6%
• Insulin Resistance 6%
• Mitogen Activated Protein Kinase 6%
• Acute Heart Infarction 6%
• Protein Kinase C 6%
• Phosphatidylinositol 3 Kinase 6%
• 1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene 6%
• Antigen 6%
• Plasminogen 6%
• Simvastatin 6%
• Intraperitoneal Injection 6%
• Luciferase 6%
• 2 Morpholino 8 Phenylchromone 6%
• Sterol Regulatory Element Binding Protein 6%

Medicine and Dentistry

• Plasminogen Activator Inhibitor-1 100%
• Messenger RNA 37%
• Cardiovascular Risk 18%
• Protein 12%
• Promoter Region 12%
• Cells 6%
• U0126 6%
• Plasma 6%
• Inpatient 6%
• Membrane 6%
• Assay 6%
• Stimulation 6%
• Intraperitoneal Drug Administration 6%
• Insulin Resistance 6%
• Antigen 6%
• 2 (2 Amino 3 Methoxyphenyl)chromone 6%
• Mitogen-Activated Protein Kinase 6%
• Protein Kinase C 6%
• Phosphoinositide 3-Kinase 6%
• Plasminogen 6%
• Transient Transfection 6%
• Simvastatin 6%
• Fibrinolysis 6%
• Luciferase 6%
• Hepatoma Cell 6%
• Pleiotropy 6%
• Quantitative Reverse Transcription Polymerase Chain Reaction 6%
• Acute Heart Infarction 6%
• LY294002 6%